26 related articles for article (PubMed ID: 38452580)
1. Proteomics-Derived Biomarker Panel Facilitates Distinguishing Primary Lung Adenocarcinomas With Intestinal or Mucinous Differentiation From Lung Metastatic Colorectal Cancer.
Liu J; Chang X; Qian L; Chen S; Xue Z; Wu J; Luo D; Huang B; Fan J; Guo T; Nie X
Mol Cell Proteomics; 2024 May; 23(5):100766. PubMed ID: 38608841
[TBL] [Abstract][Full Text] [Related]
2. Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 Tumors.
Menz A; Lony N; Lennartz M; Dwertmann Rico S; Schlichter R; Kind S; Reiswich V; Viehweger F; Dum D; Luebke AM; Kluth M; Gorbokon N; Hube-Magg C; Bernreuther C; Simon R; Clauditz TS; Sauter G; Hinsch A; Jacobsen F; Marx AH; Steurer S; Minner S; Burandt E; Krech T; Lebok P; Weidemann S
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786342
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.
Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT
Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132
[TBL] [Abstract][Full Text] [Related]
4. FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors.
Dum D; Ocokoljic A; Lennartz M; Hube-Magg C; Reiswich V; Höflmayer D; Jacobsen F; Bernreuther C; Lebok P; Sauter G; Luebke AM; Burandt E; Marx AH; Simon R; Clauditz TS; Minner S; Menz A; Büscheck F; Gorbokon N; Steurer S; Blessin NC; Krech T
Virchows Arch; 2022 Dec; 481(6):945-961. PubMed ID: 35951102
[TBL] [Abstract][Full Text] [Related]
5. CDH17+/CDX2+ Can be Helpful in Providing Support for Small Intestinal Origin Versus Pancreatic or Biliary Origin.
Ma H; Xiao W; Wang M; Shi X
Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):541-545. PubMed ID: 33958523
[TBL] [Abstract][Full Text] [Related]
6. CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2.
Altree-Tacha D; Tyrrell J; Haas T
Arch Pathol Lab Med; 2017 Jan; 141(1):144-150. PubMed ID: 28029907
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.
Ito R; Oue N; Yoshida K; Kunimitsu K; Nakayama H; Nakachi K; Yasui W
Virchows Arch; 2005 Oct; 447(4):717-22. PubMed ID: 16044349
[TBL] [Abstract][Full Text] [Related]
8. Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors.
Jacobsen F; Pushpadevan R; Viehweger F; Freytag M; Schlichter R; Gorbokon N; Büscheck F; Luebke AM; Putri D; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Bernreuther C; Lebok P; Sauter G; Minner S; Steurer S; Simon R; Burandt E; Dum D; Lutz F; Marx AH; Krech T; Clauditz TS
Pathol Res Pract; 2024 Apr; 256():155175. PubMed ID: 38452580
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
10. Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma.
Lee NP; Poon RT; Shek FH; Ng IO; Luk JM
Biochim Biophys Acta; 2010 Dec; 1806(2):138-45. PubMed ID: 20580775
[TBL] [Abstract][Full Text] [Related]
11. Ovarian neuroendocrine carcinomas of non-small-cell type associated with surface epithelial adenocarcinomas. A study of five cases and review of the literature.
Eichhorn JH; Lawrence WD; Young RH; Scully RE
Int J Gynecol Pathol; 1996 Oct; 15(4):303-14. PubMed ID: 8886877
[TBL] [Abstract][Full Text] [Related]
12. Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer.
Meng W; Gu T; Gao LM; Zong ZG; Meng L; Fu ZZ; Guo L
Braz J Med Biol Res; 2015 Dec; 48(12):1077-86. PubMed ID: 26421870
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
